İç Hastalıkları
Synopsis
The document emphasizes that anemia is not a disease itself, but rather a clinical and laboratory finding leading to tissue hypoxia. It states that along with medical history and physical examination, laboratory tests such as complete blood count, MCV, reticulocyte count, and peripheral blood smear play a critical role in diagnosis and etiological investigation. Anemias are classified as microcytic, macrocytic, and normocytic based on mean corpuscular volume (MCV). Iron deficiency anemia is the most common condition in the microcytic group, diagnosed through iron panels, ferritin levels, and the investigation of underlying causes such as gastrointestinal bleeding. Vitamin B12 deficiency in the macrocytic group stems from nutritional deficiencies or malabsorption, with neurological symptoms potentially developing prior to anemia. Furthermore, the pathophysiology, diagnostic methods, and therapeutic approaches for specific conditions—including anemia of chronic disease, autoimmune hemolytic anemias, hereditary spherocytosis, G6PD deficiency, sickle cell anemia, and thalassemias—are discussed in detail. Management options involve oral or parenteral medications, dietary adjustments, treating underlying diseases, blood transfusions, and, when indicated, splenectomy or stem cell transplantation.
References
Türk Hematoloji Derneği Eritrosit Hastalıkları ve Hemoglobin Bozuklukları Tanı ve Tedavi Kılavuzu, Eylül 2019
Beta Talasemi Taşıyıcılığı Olan Bireylerde Metabolik Sendrom ve Bileşenlerinin Sıklığı, İç Hastalıkları Uzmanlık Tezi, Dr. Ali Turhan, ADANA-2013
Beta Talasemi Taşıyıcılığı Olan Hastalarda Depresyon Sıklığı, Uzmanlık Tezi, Dr. Fevziye Gülçin Turhan, ADANA-2013
Michalak SS, Rupa-Matysek J, Gil L. Comorbidities, repeated hospitalizations, and age≥80 years as indicators of anemia development in the older population. Ann Hematol 2018; 97:1337.
Means RT. Iron Deficiency and Iron Deficiency Anemia: Implications and Impact in Pregnancy, Fetal Development, and Early Childhood Parameters. Nutrients 2020; 12.
Otto JM, Montgomery HE, Richards T. Haemoglobin concentration and mass as determinants of exercise performance and of surgical outcome. Extrem Physiol Med 2013; 2:33.
Phillips R, Wood H, Weaving G, Chevassut T. Changes in full blood count parameters with age and sex: results of a survey of almost 900 000 patient samples from primary care. Br J Haematol 2021; 192:e102.
Mentzer WC Jr. Differentiation of iron deficiency from thalassaemia trait. Lancet 1973; 1:882.
Calero F, Villegas A, Porres A, et al. Hematologic data in 825 cases of beta-thalassemia trait in Spain. Nouv Rev Fr Hematol 1990; 32:265.
Hvas A-M, Nexo E. Diagnosis and treatment of vitamin B12 deficiency. An update. Haematologica 2006;91:1506-1512.
Mast AE, Bialkowski W, Bryant BJ, et al. A randomized, blinded, placebocontrolled trial of education and iron supplementation for mitigation of iron deficiency in regular blood donors. Transfusion 2016;56:1588.
Cook JD, Skikne BS. Iron deficiency: definition and diagnosis. J Intern Med 1989;226:349.
Lechner K, Jager U. How I treat autoimmune hemolytic anemias in adults. Blood 2010;116:1831-1838.
Barros MMO, Blajchman MA, Bordin JO. Warm autoimmune hemolytic anemia: recent progress in understanding the immunobiology and the treatment. Transfus Med Rev 2010;24:195-210.
Garraty G. Immune hemolytic anemia associated with drug therapy. Blood Rev 2010;24:143-150.
Weiss G, Goodnough LT. Anemia of chronic disease. N Engl J Med 2005; 352: 1011.
Weiss G. Pathogenesis and treatment of anemia of chronic disease. Blood Rev 2002; 16:87.
Thomas DW, Hinchliffe RF, Briggs C, et al. Guideline for the laboratory diagnosis of functional iron deficiency. Br J Haematol 2013; 161:639.
Disorders of red cell membrane. Br J Haematol 2008;141:367-375.
Hereditary spherocytosis. Lancet 2008;372:1411-1426.
Glucose-6-phosphate dehydrogenase deficiency and hemolytic anemia. In: Nathan DG, Orkin SH, eds. Nathan And Oski’s Hematology Of İnfancy and Childhood. 8th ed. Philadelphia: W. B. Saunders, 2015:609-629.
Recent advances in improving the management of sickle cell disease. Blood Rev 2009;23:9-13,
TIF-Guidelines for the clinical management of thalassemia. 3nd revised edition 2014.